HIV Prevention Preparedness Study in Russia, China, and India

• Register: ClinicalTrials.gov
• Last refreshed on: 5 November 2012
• Main ID: NCT00021775
• Date of registration: 04/08/2001
• Primary sponsor: National Institute of Allergy and Infectious Disease (NIAID)
• Public title: HIV Prevention Preparedness Study in Russia, China, and India
• Scientific title: HIV Prevention Preparedness Study
• Date of first enrolment: April 2002
• Target sample size: 2000
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00021775
• Study type: Observational
• Study design: N/A

Countries of recruitment

China, India, Russian Federation, United States

Contacts

• Name: Robert Ryder

Key inclusion & exclusion criteria

Inclusion Criteria

Participants may be eligible for this study if they:

- Are 16 (Saint Petersburg) or 18 (Xinjiang, Guangxi, and Chennai) years of age or
older.

- Are HIV sero-negative.

- Are available for 12 months of study participation.

- Have written consent of parent or legal guardian if under age.

- Are able and willing to provide information on where they can be located or
contacted.

- Meet specific risk-group requirements, for women at heterosexual risk, for men at
heterosexual risk, and for injection drug users.

Exclusion Criteria

Participants will not be eligible for this study if they:

- Have any mental disorders that would cause a problem with the informed consent or
study participation.

- Have any condition that, in the opinion of the doctor, would interfere with the
study.



Age minimum: 14 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

HIV Infections

Secondary ID(s)

10611

HPTN 033

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Mental Health (NIMH)

National Institute on Drug Abuse (NIDA)